Maha Mrityunjaya USA LLC – Trademark Portfolio

Entity Type: 16

Maha Mrityunjaya USA LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MAHA MRITYUNJAYA PLANT BASED NANOTECHNOLOGY COFLU PROTECTOR HELPS IN DEVELOPING IMMUNITY AGAINST ALL FLUS WITH SPECIAL BOTANICALS & HERBALS. The owner is based in Parker, CO.

Parker, CO 80134

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Maha Mrityunjaya USA LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Maha Mrityunjaya USA LLC have?

Maha Mrityunjaya USA LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Maha Mrityunjaya USA LLC file in?

Maha Mrityunjaya USA LLC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Maha Mrityunjaya USA LLC's most well-known trademarks?

Maha Mrityunjaya USA LLC's registered trademark portfolio includes well-known marks such as MAHA MRITYUNJAYA PLANT BASED NANOTECHNOLOGY COFLU PROTECTOR HELPS IN DEVELOPING IMMUNITY AGAINST ALL FLUS WITH SPECIAL BOTANICALS & HERBALS. These are among 1 currently registered trademark in the portfolio.

What is Maha Mrityunjaya USA LLC's trademark registration success rate?

Maha Mrityunjaya USA LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.